Prosecution Insights
Browse Companies Examiners Firms Draft Your Response
Home / Examiner: MOSHER, ERIC PARKER
Last updated: August 16, 2026

Examiner: MOSHER, ERIC PARKER

Tech Center 1600 • Art Units: 1600 1612 1646

This examiner grants 100% of resolved cases

Performance Statistics

100.0%
Allow Rate
+40.0% vs TC avg
15
Total Applications
+0.0%
Interview Lift
1095
Avg Prosecution Days
Based on 1 resolved cases, 2023–2026

Rejection Statute Breakdown

1.4%
§101 Eligibility
11.0%
§102 Novelty
32.9%
§103 Obviousness
31.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18575098 RADIOLABELED PARP INHIBITOR CONJUGATES FOR CANCER TREATMENT Non-Final OA DUKE UNIVERSITY
18554521 CONTROL OF PROTEIN EXPRESSION WITH TMP-PROTAC COMPOUNDS Non-Final OA THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
18578888 PORPHYRIN NANOVESICLE WITH FATTY ACID CONJUGATE Non-Final OA UNIVERSITY HEALTH NETWORK
18546311 DUAL MODE RADIOTRACER AND THERAPEUTICS Non-Final OA Technische Universität München
18684207 DNP-NMR POLARIZING AGENT, METHOD FOR MANUFACTURING SAME, AND METHOD FOR USING SAME Non-Final OA OSAKA UNIVERSITY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Data sourced from USPTO Patent File Wrapper (daily) and Office Action Archive (weekly). Analysis generated by IP Author.

Data: USPTO Patent File Wrapper (daily) • Office Action Archive (weekly) • 89M+ prosecution events

© 2026 IP Author — Browse Office Actions • Examiners • Companies • Firms

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month